MBP and myeloid sarcoma: Moreover, given that up to half of MBP molecules are citrullinated in patients with less aggressive forms of MS and current evidence suggests that other myelin proteins are also targets of deimination [63], our findings may have broad significance for treating a spectrum of MS patients.